Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a11-4584_18k.htm

Exhibit 99

 

 

SILICON LABORATORIES REPORTS FOURTH QUARTER AND YEAR END RESULTS

 

COMPANY DELIVERS RECORD REVENUE FOR 2010—

 

AUSTIN, Texas — Jan. 26, 2011 — Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported revenue of $112 million for the fourth quarter and record revenue for the full year of $493 million.

 

2010 Highlights

 

·                  Year over year growth was driven by record revenue for the company’s broad-based products, which grew by nearly 50 percent over 2009 and represented 35 percent of total revenue for the year.

 

·                  A sustained focus on R&D resulted in 17 new product family introductions during the year spanning MCUs, Embedded Wireless, Isolation, Human Interface, Timing, Video, AM/FM Radio and Power over Ethernet.

 

·                  The company achieved a record number of design wins, broadened its sales channel and expanded its design team, all strong building blocks for future growth.

 

·                  Gross margin on both a GAAP and non-GAAP basis was at record levels for the year resulting from cost improvements and mix shifts to broad-based products.

 

·                  The company delivered 18 percent GAAP operating income and 26 percent non-GAAP operating income for the year.

 

·                  Cash generation continued to be very strong, enabling $140 million in share repurchases, two strategic technology acquisitions and a year-end cash, cash equivalents and investments balance of $383 million.

 

Fourth Quarter Highlights

 

Fourth quarter revenue of $112 million exceeded guidance and represented a seven percent

 



 

sequential decrease. The better than anticipated result for the quarter was due to stronger than anticipated demand for the company’s broad-based products and the early stages of the company’s ramp into iDTVs with its silicon TV tuner.

 

Fourth quarter GAAP gross margin was 63.5 percent. R&D investment increased to $32.6 million while SG&A decreased again to $27.5 million. Fully diluted GAAP earnings per share were $0.28 for the quarter.

 

The following non-GAAP results exclude the impact of stock compensation expense. Non-GAAP gross margin was 63.9 percent for the quarter. R&D investment increased sequentially to $28.5 million. SG&A expense declined to $22.8 million. Fully diluted non-GAAP earnings per share were $0.46. The reconciling charges are set forth in the financial measures table included below.

 

2011 Business Outlook

 

The company anticipates 2011 will be another growth year, with strong contributions from both the broadcast and broad-based businesses. Specifically, the company expects its video business to ramp and triple in size, while the timing business is expected to deliver high double-digit growth again in 2011. Both product lines are benefiting from new product ramps and an expanding footprint enabling strong market share gains.

 

“We believe the investments we’ve been making in our business over the last couple of years will begin delivering a strong return in 2011,” said Necip Sayiner, president and CEO of Silicon Laboratories. “Organic new product developments complemented by strategic acquisitions like the SpectraLinear deal we announced today, have given us a platform for continually expanding our share of the market. We expect to benefit from such product cycles and are therefore anticipating a revenue increase of approximately four to nine percent in the first quarter.”

 

The company guided revenue for the first quarter in the range of $116 to $122 million.

 



 

Webcast and Conference Call

 

A conference call discussing the quarterly results and the acquisition of SpectraLinear, also announced today, will follow this press release at 7:30 a.m. central time. An audio webcast will be available simultaneously on Silicon Laboratories’ website under Investor Relations (www.silabs.com).  A replay will be available after the call at the same website listed above or by calling 1 (800) 642-1687 or +1 (706) 645-9291 (international) and by entering 38360353. The replay will be available through February 9, 2011.

 

About Silicon Laboratories Inc.

 

Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories’ diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.

 

Forward Looking Statements

 

This press release contains forward-looking statements based on Silicon Laboratories’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; inventory-related risks; risks associated with acquisitions; difficulties managing international activities; difficulties managing our manufacturers and subcontractors; risks that Silicon Laboratories may not be able to manage strains associated with

 



 

its growth; credit risks associated with our accounts receivable; dependence on key personnel; risks associated with divestitures; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Laboratories’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories’ filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Year Ended

 

 

 

January 1,
2011

 

January 2,
2010

 

January 1,
2011

 

January 2,
2010

 

Revenues

 

$

111,891

 

$

127,190

 

$

493,341

 

$

441,020

 

Cost of revenues

 

40,800

 

43,930

 

169,097

 

161,267

 

Gross margin

 

71,091

 

83,260

 

324,244

 

279,753

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

32,621

 

26,553

 

123,821

 

104,394

 

Selling, general and administrative

 

27,456

 

30,629

 

113,752

 

108,848

 

Operating expenses

 

60,077

 

57,182

 

237,573

 

213,242

 

Operating income

 

11,014

 

26,078

 

86,671

 

66,511

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

479

 

640

 

2,318

 

2,725

 

Interest expense

 

(11

)

(25

)

(77

)

(180

)

Other income (expense), net

 

24

 

(388

)

(1,253

)

(90

)

Income before income taxes

 

11,506

 

26,305

 

87,659

 

68,966

 

Provision (benefit) for income taxes

 

(1,377

)

(13,946

)

14,417

 

(4,126

)

 

 

 

 

 

 

 

 

 

 

Net income

 

$

12,883

 

$

40,251

 

$

73,242

 

$

73,092

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.29

 

$

0.88

 

$

1.63

 

$

1.62

 

Diluted

 

$

0.28

 

$

0.84

 

$

1.57

 

$

1.57

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

43,834

 

45,650

 

44,845

 

45,023

 

Diluted

 

45,658

 

47,786

 

46,742

 

46,542

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
January 1, 2011

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Non-GAAP
Measure

 

Non-GAAP
Percent of
Revenue

 

Revenues

 

$

111,891

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

71,091

 

63.5

%

$

361

 

$

71,452

 

63.9

%

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

32,621

 

29.2

%

4,095

 

28,526

 

25.5

%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

27,456

 

24.5

%

4,607

 

22,849

 

20.4

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

60,077

 

53.7

%

8,702

 

51,375

 

45.9

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

11,014

 

9.8

%

9,063

 

20,077

 

17.9

%

 

 

 

Three Months Ended
January 1, 2011

 

Non-GAAP Diluted
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense

 

Non-GAAP
Measure

 

Net income

 

$

12,883

 

$

7,929

 

$

20,812

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

45,658

 

 

45,658

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.28

 

 

 

$

0.46

 

 

 

 

Year Ended
January 1, 2011

 

Non-GAAP Income
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Non-GAAP
Measure

 

Non-GAAP
Percent of
Revenue

 

Revenues

 

$

493,341

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

324,244

 

65.7

%

$

1,435

 

$

325,679

 

66.0

%

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

86,671

 

17.6

%

40,324

 

126,995

 

25.7

%

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

January 1,
2011

 

January 2,
2010

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

138,567

 

$

195,737

 

Short-term investments

 

227,295

 

214,486

 

Accounts receivable, net of allowance for doubtful accounts of $772 at January 1, 2011 and $567 at January 2, 2010

 

45,030

 

56,128

 

Inventories

 

39,450

 

31,512

 

Deferred income taxes

 

9,140

 

7,620

 

Prepaid expenses and other current assets

 

34,447

 

18,515

 

Total current assets

 

493,929

 

523,998

 

Long-term investments

 

17,500

 

24,676

 

Property and equipment, net

 

29,945

 

27,785

 

Goodwill

 

112,296

 

105,109

 

Other intangible assets, net

 

53,242

 

41,886

 

Other assets, net

 

20,746

 

19,384

 

Total assets

 

$

727,658

 

$

742,838

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

24,433

 

$

28,759

 

Accrued expenses

 

25,604

 

25,399

 

Deferred income on shipments to distributors

 

26,127

 

28,470

 

Income taxes

 

3,692

 

6,011

 

Total current liabilities

 

79,856

 

88,639

 

Long-term obligations and other liabilities

 

22,372

 

24,403

 

Total liabilities

 

102,228

 

113,042

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock—$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$0.0001 par value; 250,000 shares authorized; 43,933 and 45,772 shares issued and outstanding at January 1, 2011 and January 2, 2010, respectively

 

4

 

5

 

Additional paid-in capital

 

49,947

 

128,262

 

Retained earnings

 

579,127

 

505,885

 

Accumulated other comprehensive loss

 

(3,648

)

(4,356

)

Total stockholders’ equity

 

625,430

 

629,796

 

Total liabilities and stockholders’ equity

 

$

727,658

 

$

742,838

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

 

 

 

Year Ended

 

 

 

January 1,
2011

 

January 2,
2010

 

Operating Activities

 

 

 

 

 

Net income

 

$

73,242

 

$

73,092

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

11,797

 

11,887

 

Loss on disposal of property and equipment

 

21

 

33

 

Amortization of other intangible assets and other assets

 

7,494

 

7,842

 

Stock compensation expense

 

40,324

 

43,974

 

Income tax benefit from employee stock-based awards

 

3,295

 

2,422

 

Excess income tax benefit from employee stock-based awards

 

(2,412

)

(1,862

)

Deferred income taxes

 

(552

)

1,896

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

11,342

 

(19,657

)

Inventories

 

(7,811

)

(3,216

)

Prepaid expenses and other assets

 

(5,321

)

3,362

 

Accounts payable

 

(777

)

8,036

 

Accrued expenses

 

(2,590

)

(825

)

Deferred income on shipments to distributors

 

(2,343

)

6,871

 

Income taxes

 

(7,774

)

(12,914

)

Net cash provided by operating activities

 

117,935

 

120,941

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(357,777

)

(237,968

)

Proceeds from sales and maturities of marketable securities

 

352,779

 

153,275

 

Purchases of property and equipment

 

(13,850

)

(8,943

)

Purchases of other assets

 

(8,372

)

(6,408

)

Acquisitions of businesses, net of cash acquired

 

(28,021

)

(4,300

)

Net cash used in investing activities

 

(55,241

)

(104,344

)

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from issuance of common stock, net of shares withheld for taxes

 

18,055

 

25,187

 

Excess income tax benefit from employee stock-based awards

 

2,412

 

1,862

 

Repurchases of common stock

 

(140,331

)

(20,181

)

Net cash provided by (used in) financing activities

 

(119,864

)

6,868

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

(57,170

)

23,465

 

Cash and cash equivalents at beginning of period

 

195,737

 

172,272

 

Cash and cash equivalents at end of period

 

$

138,567

 

$

195,737

 

 

 #  #  #